Austin Burns
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Austin Burns has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Sima Rozati
Department of Dermatology Johns Hopkins University School of Medicine Baltimore Maryland USA
2 shared publications Amarachi Eseonu
Department of Dermatology, Johns Hopkins University, Baltimore, MD, United States
1 shared publicationAravind Krishnan
Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
1 shared publication- Atul Dhall
Department of Preventive and Restorative Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA
1 shared publication - Bradley D. Kwinta
Vagelos College of Physicians and Surgeons Columbia University New York New York USA
1 shared publication - Connor Stonesifer
University of Miami Miller School of Medicine Miami Florida USA
1 shared publication
Latest Publications
- Open Access
- 12 November 2022
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 88 (4) , 935-937
International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study
- 12 November 2022
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 88 (4) , 935-937
Open AccessInternational Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study
- 1 October 2021
- Published by Elsevier in European Journal of Cancer
- Vol. 156, S31
The role of illness perception in patients with cutaneous T-cell lymphoma
- 1 October 2021
- Published by Elsevier in European Journal of Cancer
- Vol. 156, S31
The role of illness perception in patients with cutaneous T-cell lymphoma
- 28 February 2019
- Published by IMR Press in The Heart Surgery Forum
- Vol. 22 (2) , E103-E106
Delayed Surgical Management of Type A Intramural Hematoma Is Not Associated with Worse Outcomes Than Emergent Operation
Objectives: Management of acute aortic intramural hematomas (IMHs) involving the ascending aorta and root remains controversial. Some series have suggested that delaying operative intervention beyond the first 24-hours may be beneficial. Methods: A retrospective single-institution analysis was performed to identify patients presenting with type A IMH. These patients were classified by whether they underwent surgery within 24 hours or delayed operative intervention. Patients with additional indications for emergent operation, such as acute aortic regurgitation or malperfusion syndromes, were excluded. Outcomes were assessed with logistic regression, and the Kaplan–Meier method was used to analyze long-term survival. Results: Of the 129 patients with acute type A aortic pathology, 36 (27.9%) presented with isolated IMH. IMH patients were less likely to present with acute aortic regurgitation (8.6% versus 27.9%, P = .020) or limb ischemia (0% versus 12.6%, P = .027). Of the IMH patients without other emergent operative indications, 23 (67.6%) underwent surgery within 24 hours. Delayed operative repair was not associated with increased risk of mortality, stroke, or renal failure (all P >.05). Survival analysis showed no difference in survival at 1 year. Conclusions: In well-selected patients, delayed operation for type An intramural hematoma is not associated with adverse outcomes.
- 28 February 2019
- Published by IMR Press in The Heart Surgery Forum
- Vol. 22 (2) , E103-E106
Delayed Surgical Management of Type A Intramural Hematoma Is Not Associated with Worse Outcomes Than Emergent Operation
Objectives: Management of acute aortic intramural hematomas (IMHs) involving the ascending aorta and root remains controversial. Some series have suggested that delaying operative intervention beyond the first 24-hours may be beneficial. Methods: A retrospective single-institution analysis was performed to identify patients presenting with type A IMH. These patients were classified by whether they underwent surgery within 24 hours or delayed operative intervention. Patients with additional indications for emergent operation, such as acute aortic regurgitation or malperfusion syndromes, were excluded. Outcomes were assessed with logistic regression, and the Kaplan–Meier method was used to analyze long-term survival. Results: Of the 129 patients with acute type A aortic pathology, 36 (27.9%) presented with isolated IMH. IMH patients were less likely to present with acute aortic regurgitation (8.6% versus 27.9%, P = .020) or limb ischemia (0% versus 12.6%, P = .027). Of the IMH patients without other emergent operative indications, 23 (67.6%) underwent surgery within 24 hours. Delayed operative repair was not associated with increased risk of mortality, stroke, or renal failure (all P >.05). Survival analysis showed no difference in survival at 1 year. Conclusions: In well-selected patients, delayed operation for type An intramural hematoma is not associated with adverse outcomes.
- 12 July 2017
- Published by Royal Society of Chemistry (RSC) in Environmental Science: Nano
- Vol. 4 (8) , 1742-1749
Characterizing the phosphatase mimetic activity of cerium oxide nanoparticles and distinguishing its active site from that for catalase mimetic activity using anionic inhibitors
Cerium oxide nanoparticles (CeNPs) are potent reactive oxygen and nitrogen species scavengers and demonstrate beneficial antioxidant properties in both cell culture and animal studies.
- 12 July 2017
- Published by Royal Society of Chemistry (RSC) in Environmental Science: Nano
- Vol. 4 (8) , 1742-1749
Characterizing the phosphatase mimetic activity of cerium oxide nanoparticles and distinguishing its active site from that for catalase mimetic activity using anionic inhibitors
Cerium oxide nanoparticles (CeNPs) are potent reactive oxygen and nitrogen species scavengers and demonstrate beneficial antioxidant properties in both cell culture and animal studies.